Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes
about
High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes.Modified Lipoproteins in Diabetic Retinopathy: A Local Action in the RetinaB lymphocytes as emerging mediators of insulin resistance.Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women.Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for interventionDetection of circulating IgG antibodies to apolipoprotein B100 in acute myocardial infarction.Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers.Extravascular modified lipoproteins: a role in the propagation of diabetic retinopathy in a mouse model of type 1 diabetes.Proteomic Insight Reveals Elevated Levels of Albumin in Circulating Immune Complexes in Diabetic Plasma.Elevated Levels of Plasma IgA Autoantibodies against Oxidized LDL Found in Proliferative Diabetic Retinopathy but Not in Nonproliferative RetinopathyImmune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytesB cells as under-appreciated mediators of non-auto-immune inflammatory disease.Atherosclerosis, diabetes and lipoproteins.State of the union between metabolism and the immune system in type 2 diabetes.Targeting inflammation in cardiovascular diseases. still a neglected field?Vaccines against atherosclerosis.B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance.Obesity modulates the immune response to oxidized LDL in hypertensive patients.Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.Clinical and Pathological Significance of Autoantibodies to Erythropoietin Receptor in Type 2 Diabetic Patients With CKD.
P2860
Q33930928-2BAD9805-3989-44C4-94C9-BF7C4BA34A1BQ33942486-20542DF9-8F97-4844-88B1-B1A1CCA3A52FQ33942560-612BE4CD-7528-426C-BDDE-A4740D347762Q35175305-CF5A0D3B-ECE3-4A22-91A0-75F5A26C6883Q35998510-DD5892F2-11F5-4AE5-9E9C-53E506BECE4AQ36042620-DD5A8BE4-F65D-4BBA-9131-28263116E83EQ36117585-0E879EE6-CC53-4C75-995B-28E06480BF0EQ37143813-BC22C1BE-0795-40DC-A4A1-C882DD3C642AQ37372290-9C68D1CD-F091-4498-823B-4CA577286663Q37549608-41B47284-338D-445B-B97D-6E3989C583C2Q37716355-30417795-07EB-4605-8B4F-9E7FD8BFD088Q37728724-5718506F-5ED1-490A-A4D4-45ADAD63AEB7Q37770113-B5FBD354-1D7D-48C4-8112-86498E36048FQ37851349-2374A27E-6573-4487-A615-0E794962C655Q37925018-917A2BAD-FE15-4326-896C-A13D5009971FQ38089941-37C66EE0-7D92-4BCB-A849-D2B7A5E11D2CQ38152732-DC342CA8-2ACB-4F4B-9672-F38B783420C5Q38316537-5732FB8B-1ED0-470F-B42A-BA5C59955A61Q49072554-8C87467E-13CA-4A7B-9D64-DBB2BCB91BC4Q49409256-5D861696-34A4-4EAA-B540-B26677562136
P2860
Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Associations between autoantib ...... patients with type 2 diabetes
@en
Associations between autoantib ...... patients with type 2 diabetes.
@nl
type
label
Associations between autoantib ...... patients with type 2 diabetes
@en
Associations between autoantib ...... patients with type 2 diabetes.
@nl
prefLabel
Associations between autoantib ...... patients with type 2 diabetes
@en
Associations between autoantib ...... patients with type 2 diabetes.
@nl
P2093
P2860
P1433
P1476
Associations between autoantib ...... patients with type 2 diabetes
@en
P2093
E Bengtsson
G N Fredrikson
P2860
P2888
P304
P356
10.1007/S00125-009-1377-9
P577
2009-05-12T00:00:00Z